Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Intervention and Therapeutics
Published in: Cardiovascular Intervention and Therapeutics 1/2020

01-01-2020 | Angiography | Invited Review Article

Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography

Published in: Cardiovascular Intervention and Therapeutics | Issue 1/2020

Login to get access

Abstract

Individual studies IVUS vs angiography-guided DES implantation studies, whether randomized clinical trials or registries are underpowered, to show a reduction in mortality, especially at 1 year of follow-up. However, either meta-analyses or the few studies with long-term (> 5 year) follow-up showed that IVUS guidance reduced mortality and improved patient survival, even with second-generation DES.
Literature
1.
Jakabcin J, Spacek R, Bystron M, et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv. 2010;75:578–83.PubMed
2.
Chieffo A, Latib A, Caussin C, et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013;165:65–72.PubMed
3.
Kim JS, Kang TS, Mintz GS, et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv. 2013;6:369–76.PubMed
4.
Hong SJ, Kim BK, Shin DH, IVUS-XPL Investigators, et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314:2155–63.PubMed
5.
Tian NL, Gami SK, Ye F, et al. Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015;10:1409–17.PubMed
6.
Kim BK, Shin DH, Hong MK, CTO-IVUS Study Investigators, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation: randomized study. Circ Cardiovasc Interv. 2015;8:e002592.PubMed
7.
Tan Q, Wang Q, Liu D, et al. Intravascular ultrasound–guided unprotected left main coronary artery stenting in the elderly. Saudi Med J. 2015;36:549–53.PubMedPubMedCentral
8.
Zhang JQ, Shi R, Pang W, et al. Application of intravascular ultrasound in stent implantation for small coronary arteries. J Clin Invasive Cardiol. 2016;3:1–8.
9.
Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014;7:1287–93.PubMedPubMedCentral
10.
Zhang J, Gao X, Kan J, et al. Intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stent in all-comers: the ULTIMATE trial. J Am Coll Cardiol. 2018;72:3126–37.PubMed
11.
Liu XM, Yang ZM, Liu XK, et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: a single-center randomized trial. Anatol J Cardiol. 2019;21:83–90.PubMed
12.
Agostoni P, Valgimigli M, Van Mieghem CA, et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol. 2005;95:644–7.PubMed
13.
Roy P, Steinberg DH, Sushinsky SJ, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008;29:1851–7.PubMed
14.
Fujimoto H, Tao S, Dohi T, et al. Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone. J Cardiol. 2008;51:18–24.PubMed
15.
Park SJ, Kim YH, Park DW, Investigators M-C, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167–77.PubMed
16.
Kim SH, Kim YH, Kang SJ, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol. 2010;106:612–8.PubMed
17.
Maluenda G, Lemesle G, Ben-Dor I, et al. Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75:86–92.PubMed
18.
Claessen BE, Mehran R, Mintz GS, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv. 2011;4:974–81.PubMed
19.
Kim JS, Hong MK, Ko YG, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registry. Am Heart J. 2011;161:180–7.PubMed
20.
Youn YJ, Yoon J, Lee JW, et al. Intravascular ultrasound-guided primary percutaneous coronary intervention with drug-eluting stent implantation in patients with ST-segment elevation myocardial infarction. Clin Cardiol. 2011;34:706–13.PubMedPubMedCentral
21.
Chen SL, Ye F, Zhang JJ, et al. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions and reduced late stent thrombosis. Catheter Cardiovasc Interv. 2013;81:456–63.PubMed
22.
Hur SH, Kang SJ, Kim YH, et al. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv. 2013;81:407–16.PubMed
23.
Park KW, Kang SH, Yang HM, et al. Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial. Int J Cardiol. 2013;167:721–6.PubMed
24.
Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the ADAPT-DES Study. Circulation. 2014;129:463–70.PubMed
25.
Ahn SG, Yoon J, Sung JK, et al. Intravascular ultrasound-guided percutaneous coronary intervention improves the clinical outcome in patients undergoing multiple overlapping drug-eluting stents implantation. Korean Circ J. 2013;43:231–8.PubMedPubMedCentral
26.
Ahn JM, Han S, Park YK, RESET Investigators, et al. Differential prognostic effect of intravascular ultrasound use according to implanted stent length. Am J Cardiol. 2013;111:829–35.PubMed
27.
Yoon YW, Shin S, Kim BK, Investigators R, et al. Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents. Am J Cardiol. 2013;112:642–6.PubMed
28.
de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, IVUS-TRONCO-ICP Spanish study, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014;7:244–54.PubMed
29.
Hong SJ, Kim BK, Shin DH, K-CTO Registry, et al. Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry). Am J Cardiol. 2014;114:534–40.PubMed
30.
Gao XF, Kan J, Zhang YJ, et al. Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. Patient Prefer Adher. 2014;8:1299–309.
31.
Fröhlich GM, Redwood S, Rakhit R, et al. Long-term survival in patients undergoing percutaneous interventions with or without intracoronary pressure wire guidance or intracoronary ultrasonographic imaging: a large cohort study. JAMA Intern Med. 2014;174:1360–6.PubMed
32.
Yazici HU, Agamaliyev M, Aydar Y, Goktekin O. The impact of intravascular ultrasound guidance during drug eluting stent implantation on angiographic outcomes. Eur Rev Med Pharmacol Sci. 2015;19:3012–7.PubMed
33.
Singh V, Badheka AO, Arora S, et al. Comparison of in-hospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus angiography. Am J Cardiol. 2015;115:1357–66.PubMed
34.
Magalhaes MA, Minha S, Torguson R, et al. The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drug-eluting stent era. EuroIntervention. 2015;11:625–33.PubMed
35.
Nakatsuma K, Shiomi H, Morimoto T, CREDO-Kyoto AMI investigators, et al. Intravascular ultrasound guidance vs angiographic guidance in primary percutaneous coronary intervention for ST segment elevation myocardial infarction—long-term clinical outcomes from the CREDO-Kyoto AMI Registry. Circ J. 2016;80:477–84.PubMed
36.
Patel Y, Depta JP, Patel JS, et al. Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions. Catheter Cardiovasc Interv. 2016;87:232–40.PubMed
37.
Ahmed K, Jeong MH, Chakraborty R, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 2011;108:8–14.PubMed
38.
Roy P, Torguson R, Okabe T, et al. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007;20:307–13.PubMed
39.
Gerber RT, Latib A, Ielasi A, et al. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc Interv. 2009;74:348–56.PubMed
40.
Biondi-Zoccai G, Sheiban I, Romagnoli E, et al. Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4314-patient registry. Clin Res Cardiol. 2011;100:1021–8.PubMed
41.
Wakabayashi K, Lindsay J, Laynez-Carnicero A, et al. Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions. J Interv Cardiol. 2012;25:452–9.PubMed
42.
Patel Y, Depta JP, Novak E, et al. Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. Am J Cardiol. 2012;109:960–5.PubMed
43.
De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, ESTROFA-LM Study Group, et al. Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry). Am J Cardiol. 2013;111:676–83.PubMed
44.
Andell P, Karlsson S, Mohammad MA, et al. Intravascular ultrasound guidance is associated with better outcome in patients undergoing unprotected left main coronary artery stenting compared with angiography guidance alone. Circ Cardiovasc Interv. 2017;10:e004813.PubMed
45.
Tian J, Guan C, Wang W, et al. Intravascular ultrasound guidance improves the long-term prognosis in patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention. Sci Rep. 2017;7:2377.PubMedPubMedCentral
46.
47.
48.
49.
Choi KH, Song YB, Lee JM, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019;12:607–20.PubMed
50.
51.
52.
Zhang Y, Farooq V, Garcia-Garcia HM, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855–65.PubMed
53.
Klersy C, Ferlini M, Raisaro A, et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol. 2013;170:54–63.PubMed
54.
Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC Cardiovasc Interv. 2014;7:233–43.PubMed
55.
Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338–47.PubMed
56.
Zhang YJ, Pang S, Chen XY, et al. Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2015;15:153.PubMedPubMedCentral
57.
Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M. The role of vascular imaging in guiding routine percutaneous coronary interventions: a meta-analysis of bare Metal stent and drug-eluting stent trials. Cardiovasc Ther. 2015;33:360–6.PubMed
58.
Nerlekar N, Cheshire CJ, Verma KP, et al. Intravascular ultrasound guidance improves clinical outcomes during implantation of both first and second-generation drug-eluting stents: a meta-analysis. EuroIntervention. 2017;12:1632–42.PubMed
59.
Steinvil A, Zhang YJ, Lee SY, et al. Intravascular ultrasound-guided drug-eluting stent implantation: an updated meta-analysis of randomized control trials and observational studies. Int J Cardiol. 2016;216:133–9.PubMed
60.
Elgendy IY, Mahmoud AN, Elgendy AY, et al. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv. 2016;9:e003700.PubMed
61.
Shin DH, Hong SJ, Mintz GS, et al. Effects of intravascular ultrasound-guided versus angiography-guided new-generation drug-eluting stent implantation: meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients. JACC Cardiovasc Interv. 2016;9:2232–9.PubMed
62.
Bavishi C, Sardar P, Chatterjee S, et al. Intravascular ultrasound–guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: meta-analysis of randomized trials. Am Heart J. 2017;185:26–34.PubMed
63.
Fan ZG, Gao XF, Li XB, et al. The outcomes of intravascular ultrasound-guided drug-eluting stent implantation among patients with complex coronary lesions: a comprehensive meta-analysis of 15 clinical trials and 8,084 patients. Anatol J Cardiol. 2017;17:258–68.PubMedPubMedCentral
64.
Ye Y, Yang M, Zhang S, Zeng Y. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: a meta-analysis. PLoS One. 2017;12(6):e0179756.PubMedPubMedCentral
65.
Raber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281–300.PubMed
66.
67.
DiMario C, Koskinas KC, Raber L. Clinical benefit of IVUS guidance for coronary stenting. J Am Coll Cardiol. 2018;72:3128–41.
68.
69.
Elgendy IY, Mahmoud AN, Elgendy AY, Mintz GS. Intravascular ultrasound-guidance is associated with lower cardiovascular mortality and myocardial infarction for drug-eluting stent implantation1insights from an updated meta-analysis of randomized trials. Circ J. 2019;83:1410–3.PubMed
70.
de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol. 2008;51:986–90.PubMed
71.
Kimura T, Morimoto T, Kozuma K, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation. 2010;122:52–61.PubMed
72.
Thayssen P, Jensen LO, Lassen JF, Western Denmark Heart Registry, et al. The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation. EuroIntervention. 2012;8:591–8.PubMed
73.
Secemsky EA, Matteau A, Yeh RW, PROTECT Trial Investigators, et al. Comparison of short- and long-term cardiac mortality in early versus late stent thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015;115:1678–84.PubMed
74.
Armstrong EJ, Feldman DN, Wang TY, et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv. 2012;5:131–40.PubMed
75.
Armstrong EJ, Maddox TM, Carey EP, Grunwald GK, Shunk KA. Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: a report from the VA CART program. Am Heart J. 2014;168:560–7.PubMed
76.
77.
Goel SS, Dilip Gajulapalli R, Athappan G, et al. Management of drug eluting stent in-stent restenosis: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87:1080–91.PubMed
78.
Lee JM, Rhee TM, Hahn JY, et al. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Int J Cardiol. 2017;230:181–90.PubMed
79.
Basavarajaiah S, Naganuma T, Latib A, et al. Treatment of drug-eluting stent restenosis: comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study. Catheter Cardiovasc Interv. 2016;88:522–8.PubMed
80.
81.
Redfors B, Généreux P, Witzenbichler B, et al. Percutaneous coronary intervention of lesions with in-stent restenosis: a report from the ADAPT-DES study. Am Heart J. 2018;197:142–9.PubMed
Metadata
Title
Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography
Publication date
01-01-2020
Published in
Cardiovascular Intervention and Therapeutics / Issue 1/2020
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-019-00616-7

Other articles of this Issue 1/2020

Cardiovascular Intervention and Therapeutics 1/2020 Go to the issue

Invited Review Article

Significance of echocardiographic evaluation for transcatheter aortic valve implantation

Invited Review Article

Utility of computed tomography in cases of aortic valve stenosis before and after transcatheter aortic valve implantation

Invited Review Article

Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective

Invited Review Article

Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention

Images in Cardiovascular Intervention

Edge restenosis of a polytetrafluoroethylene-covered stent in the superficial femoral artery: insights from an imaging assessment with an electronic high-resolution angioscope

Invited Review Article

Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits